pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
mRNA-3927
Propionic Acidemia
$MRNAModerna, Inc.
0 catalysts
Phase 1
mRNA-4106
Cervical Cancer
$MRNAModerna, Inc.
0 catalysts
Phase 2
mRNA-4359
Solid Tumor
$MRNAModerna, Inc.
0 catalysts
Marketed
← prev
page 228 of 271
next →
131
Pain89
Neurology1
mafenide acetate
Sulfamylon (mafenide acetate)
Surgical Wound Infections
Mylan Pharmaceuticals Inc
0 catalysts
Preclinical
magnesium lysinate bis eicosapentaenoate
Pancreatic Cancer
Thetis Pharmaceuticals LLC
0 catalysts
Marketed
magnesium sulfate Fresenius
Magnesium Sulfate (magnesium sulfate)
Pre-Eclampsia
Fresenius Kabi USA LLC
0 catalysts
Marketed
magnesium sulfate Pfizer
Magnesium Sulfate (magnesium sulfate)
Seizures
Hospira Inc
0 catalysts
Phase 2
malaria [strain NF-54] vaccine 2
Malaria
Sanaria Inc
0 catalysts
Phase 1
malaria vaccine 3
Malaria
PATH Malaria Vaccine Initiative
0 catalysts
Marketed
malathion
Malathion
Pediculosis capitis (Head Lice Infestation)
Suven Life Sciences Ltd
0 catalysts
Marketed
mannitol
Bronchitol (mannitol)
Cystic Fibrosis
Arna Pharma Pty Ltd
0 catalysts
Marketed
maralixibat chloride
Livmarli (maralixibat chloride)
Biliary Atresia
Ileal sodium/bile acid cotransporter
$MIRMMirum Pharmaceuticals, Inc.
0 catalysts
Preclinical
maraviroc
Maraviroc (maraviroc [INN])
Parkinson's Disease
Forest Hills Partners Hong Kong Ltd
0 catalysts
Phase 2
margetuximab
Margenza (margetuximab-cmkb)
Gastric Cancer
Receptor tyrosine-protein kinase erbB-2
TerSera Therapeutics LLC
0 catalysts
Marketed
maribavir
Livtencity (maribavir)
Cytomegalovirus (HHV-5) Infections
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
marnetegragene autotemcel
Kresladi (marnetegragene autotemcel)
Leukocyte Disorders (White Blood Cell Disorders)
$RCKTROCKET PHARMACEUTICALS, INC.
0 catalysts
Phase 3
masitinib
masitinib [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
AB Science SA
0 catalysts
Phase 3
masupirdine
masupirdine [INN]
Dementia Associated With Alzheimer's Disease
Suven Life Sciences Ltd
0 catalysts
Marketed
mavacamten
Camzyos (mavacamten)
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb Co
0 catalysts
Phase 2
maveropepimut-s
Fallopian Tube Cancer
$BVAXFBioVaxys Technology Corp.
0 catalysts
Marketed
mavorixafor
Xolremdi (mavorixafor)
Neutropenia
C-X-C chemokine receptor type 4
$XFORX4 Pharmaceuticals, Inc
0 catalysts
Phase 2
mavrilimumab
Rheumatoid Arthritis
Granulocyte-macrophage colony-stimulating factor receptor
MedImmune Ltd
0 catalysts
Phase 2
mavrostobart
Solid Tumor
Phanes Therapeutics Inc
0 catalysts
Phase 2
mazindol ER
Quilience (mazindol)
Idiopathic Hypersomnia (IH)
Monoamine transporter
$NCELNewcelX Ltd.
0 catalysts
Marketed
mebendazole
Emverm (mebendazole)
Ancylostomiasis (Hookworm Infections)
$AMRXAmneal Pharmaceuticals, Inc.
0 catalysts
Phase 2
mebufotenin
mebufotenin [INN]
Treatment Resistant Depression
$ATAIAtaiBeckley Inc.
0 catalysts
Marketed
mecamylamine
Mecamylamine Hydrochloride (mecamylamine [INN])
Idiopathic (Essential) Hypertension
Tilde Sciences LLC
0 catalysts
Marketed
mecasermin
Increlex (mecasermin)
Growth Disorders
$ETONEton Pharmaceuticals, Inc.
0 catalysts
Phase 2
mecasermin rinfabate
Bronchopulmonary Dysplasia
Insulin-like growth factor 1 receptor
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
mecbotamab vedotin
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFOTubulin
$BCABBioAtla, Inc.
0 catalysts